-
Something wrong with this record ?
STAT3 inhibitor Stattic and its analogues inhibit STAT3 phosphorylation and modulate cytokine secretion in senescent tumour cells
R. Mikyskova, O. Sapeg, M. Psotka, O. Novotny, Z. Hodny, S. Balintova, D. Malinak, J. Svobodova, R. Andrys, D. Rysanek, K. Musilek, M. Reinis
Language English Country Greece
Document type Journal Article
NLK
Free Medical Journals
from 2008 to 1 year ago
Freely Accessible Science Journals
from 2008
ProQuest Central
from 2012-01-01
Health & Medicine (ProQuest)
from 2012-01-01
- MeSH
- Cytokines * metabolism MeSH
- Docetaxel pharmacology MeSH
- Gene Expression MeSH
- Phosphorylation MeSH
- Mice MeSH
- Cellular Senescence MeSH
- STAT3 Transcription Factor * metabolism MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Signal transducer and activator of transcription 3 (STAT3) signalling serves an important role in carcinogenesis and cellular senescence, and its inhibition in tumour cells represents an attractive therapeutic target. Premature cellular senescence, a process of permanent proliferative arrest of cells in response to various inducers, such as cytostatic drugs or ionizing radiation, is accompanied by morphological and secretory changes, and by altered susceptibility to chemotherapeutic agents, which can thereby complicate their eradication by cancer therapies. In the present study, the responsiveness of proliferating and docetaxel (DTX)‐induced senescent cancer cells to small molecule STAT3 inhibitor Stattic and its analogues was evaluated using tumour cell lines. These agents displayed cytotoxic effects in cell viability assays on both proliferating and senescent murine TRAMP‐C2 and TC‐1 cells; however, senescent cells were markedly more resistant. Western blot analysis revealed that Stattic and its analogues effectively inhibited constitutive STAT3 phosphorylation in both proliferating and senescent cells. Furthermore, whether the Stattic‐derived inhibitor K1836 could affect senescence induction or modulate the phenotype of senescent cells was evaluated. K1836 treatment demonstrated no effect on senescence induction by DTX. However, the K1836 compound significantly modulated secretion of certain cytokines (interleukin‐6, growth‐regulated oncogene α and monocyte chemoattractant protein‐1). In summary, the present study demonstrated differences between proliferating and senescent tumour cells in terms of their susceptibility to STAT3 inhibitors and demonstrated the ability of the new STAT3 inhibitor K1836 to affect the secretion of essential components of the senescence‐associated secretory phenotype. The present study may be useful for further development of STAT3 inhibitor‐based therapy of cancer or age‐related diseases.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23003648
- 003
- CZ-PrNML
- 005
- 20230425140758.0
- 007
- ta
- 008
- 230418s2023 gr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3892/mmr.2023.12968 $2 doi
- 035 __
- $a (PubMed)36825563
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Mikyskova, Romana $u Laboratory of Immunological and Tumour Models, Institute of Molecular Genetics of The Czech Academy of Sciences, 142 20 Prague, Czech Republic
- 245 10
- $a STAT3 inhibitor Stattic and its analogues inhibit STAT3 phosphorylation and modulate cytokine secretion in senescent tumour cells / $c R. Mikyskova, O. Sapeg, M. Psotka, O. Novotny, Z. Hodny, S. Balintova, D. Malinak, J. Svobodova, R. Andrys, D. Rysanek, K. Musilek, M. Reinis
- 520 9_
- $a Signal transducer and activator of transcription 3 (STAT3) signalling serves an important role in carcinogenesis and cellular senescence, and its inhibition in tumour cells represents an attractive therapeutic target. Premature cellular senescence, a process of permanent proliferative arrest of cells in response to various inducers, such as cytostatic drugs or ionizing radiation, is accompanied by morphological and secretory changes, and by altered susceptibility to chemotherapeutic agents, which can thereby complicate their eradication by cancer therapies. In the present study, the responsiveness of proliferating and docetaxel (DTX)‐induced senescent cancer cells to small molecule STAT3 inhibitor Stattic and its analogues was evaluated using tumour cell lines. These agents displayed cytotoxic effects in cell viability assays on both proliferating and senescent murine TRAMP‐C2 and TC‐1 cells; however, senescent cells were markedly more resistant. Western blot analysis revealed that Stattic and its analogues effectively inhibited constitutive STAT3 phosphorylation in both proliferating and senescent cells. Furthermore, whether the Stattic‐derived inhibitor K1836 could affect senescence induction or modulate the phenotype of senescent cells was evaluated. K1836 treatment demonstrated no effect on senescence induction by DTX. However, the K1836 compound significantly modulated secretion of certain cytokines (interleukin‐6, growth‐regulated oncogene α and monocyte chemoattractant protein‐1). In summary, the present study demonstrated differences between proliferating and senescent tumour cells in terms of their susceptibility to STAT3 inhibitors and demonstrated the ability of the new STAT3 inhibitor K1836 to affect the secretion of essential components of the senescence‐associated secretory phenotype. The present study may be useful for further development of STAT3 inhibitor‐based therapy of cancer or age‐related diseases.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a fosforylace $7 D010766
- 650 12
- $a transkripční faktor STAT3 $x metabolismus $7 D050796
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a docetaxel $x farmakologie $7 D000077143
- 650 12
- $a cytokiny $x metabolismus $7 D016207
- 650 _2
- $a stárnutí buněk $7 D016922
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sapeg, Olena $u Laboratory of Immunological and Tumour Models, Institute of Molecular Genetics of The Czech Academy of Sciences, 142 20 Prague, Czech Republic
- 700 1_
- $a Psotka, Miroslav $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Novotny, Ondrej $u Laboratory of Immunological and Tumour Models, Institute of Molecular Genetics of The Czech Academy of Sciences, 142 20 Prague, Czech Republic
- 700 1_
- $a Hodny, Zdeněk $u Laboratory of Genome Integrity, Institute of Molecular Genetics of The Czech Academy of Sciences, 142 20 Prague, Czech Republic
- 700 1_
- $a Balintova, Sona $u Laboratory of Immunological and Tumour Models, Institute of Molecular Genetics of The Czech Academy of Sciences, 142 20 Prague, Czech Republic
- 700 1_
- $a Malinak, David $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Svobodova, Jana $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Andrys, Rudolf $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Rysanek, David $u Laboratory of Genome Integrity, Institute of Molecular Genetics of The Czech Academy of Sciences, 142 20 Prague, Czech Republic
- 700 1_
- $a Musilek, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
- 700 1_
- $a Reinis, Milan $u Laboratory of Immunological and Tumour Models, Institute of Molecular Genetics of The Czech Academy of Sciences, 142 20 Prague, Czech Republic
- 773 0_
- $w MED00181650 $t Molecular medicine reports $x 1791-3004 $g Roč. 27, č. 4 (2023)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36825563 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425140755 $b ABA008
- 999 __
- $a ok $b bmc $g 1924367 $s 1189857
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 27 $c 4 $e 20230224 $i 1791-3004 $m Molecular medicine reports $n Mol Med Rep $x MED00181650
- LZP __
- $a Pubmed-20230418